Suppr超能文献

COX-2 抑制对前交叉韧带重建后腱骨愈合和 PGE2 浓度的影响。

Effect of COX-2 inhibition on tendon-to-bone healing and PGE2 concentration after anterior cruciate ligament reconstruction.

机构信息

Center for Musculoskeletal Surgery, University Hospital Charité, Charitéplatz 1, 10117, Berlin, Germany.

Department of Experimental Trauma Surgery, Technical University of Munich, Ismaninger Straße 22, 81675, Munich, Germany.

出版信息

Eur J Med Res. 2018 Jan 5;23(1):1. doi: 10.1186/s40001-017-0297-2.

Abstract

BACKGROUND

Non-steroidal anti-inflammatory drugs are commonly used to reduce pain and inflammation in orthopaedic patients. Selective cyclooxygenase-2 (COX-2) inhibitors have been developed to minimize drug-specific side effects. However, they are suspected to impair both bone and tendon healing. The objective of this study is to evaluate the effect of COX-2 inhibitor administration on tendon-to-bone healing and prostaglandin E (PGE2) concentration.

METHODS

Thirty-two New Zealand white rabbits underwent reconstructions of the anterior cruciate ligaments and were randomized into four groups: Two groups postoperatively received a selective COX-2 inhibitor (Celecoxib) on a daily basis for 3 weeks, the two other groups received no postoperative COX-2 inhibitors at all and were examined after three or 6 weeks. The PGE2 concentration of the synovial fluid, the osseous integration of the tendon graft at tunnel aperture and midtunnel section, as well as the stability of the tendon graft were examined via biomechanic testing.

RESULTS

After 3 weeks, the PGE2 content of the synovial fluid in the COX-2 inhibitor recipients was significantly lower than that of the control group (p = 0.018). At the same time, the COX-2 inhibitor recipients had a significantly lower bone density and lower amount of new bone formation than the control group (p = 0.020; p = 0.028) in the tunnel aperture. At the 6-week examination, there was a significant increase in the PGE2 content within synovial fluid of the COX-2 inhibitor recipients (p = 0.022), whose treatment with COX-2 inhibitors had ended 3 weeks earlier; in contrast, the transplant stability decreased and was reduced by 37% compared to the controls.

CONCLUSIONS

Selective COX-2 inhibitors cause impaired tendon-to-bone healing, weaken mechanical stability and decrease PGE2 content of the synovial fluid. The present study suggests a reluctant use of COX-2 inhibitors when tendon-to-bone healing is intended.

摘要

背景

非甾体类抗炎药常用于减轻骨科患者的疼痛和炎症。选择性环氧化酶-2(COX-2)抑制剂的开发旨在最大程度地减少药物的特异性副作用。然而,它们被怀疑会损害骨骼和肌腱的愈合。本研究旨在评估 COX-2 抑制剂给药对肌腱-骨愈合和前列腺素 E(PGE2)浓度的影响。

方法

32 只新西兰白兔行前交叉韧带重建,并随机分为四组:两组术后每天接受选择性 COX-2 抑制剂(塞来昔布)治疗 3 周,另外两组术后根本不接受 COX-2 抑制剂治疗,术后 3 或 6 周进行检查。通过生物力学测试检查滑膜液中的 PGE2 浓度、肌腱移植物在隧道口和隧道中段的骨整合以及肌腱移植物的稳定性。

结果

3 周后,COX-2 抑制剂组滑膜液中的 PGE2 含量明显低于对照组(p=0.018)。同时,COX-2 抑制剂组在隧道口处的骨密度和新骨形成量明显低于对照组(p=0.020;p=0.028)。在 6 周检查时,COX-2 抑制剂组滑膜液中的 PGE2 含量显著增加(p=0.022),该组在 3 周前已停止 COX-2 抑制剂治疗;相比之下,移植物的稳定性下降,与对照组相比降低了 37%。

结论

选择性 COX-2 抑制剂会导致肌腱-骨愈合受损、机械稳定性降低,并降低滑膜液中的 PGE2 含量。本研究表明,在需要肌腱-骨愈合时,应慎重使用 COX-2 抑制剂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e820/5756348/fa9ead877fc0/40001_2017_297_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验